Benefits of Pressure Reduction in Glaucoma

Links shared publicly online about this topic

Relieving Eye Pressure May Slow Glaucoma:

health.msn.com — “Relieving Eye Pressure May Slow Glaucoma:View full resource at health.msn.com

  • View Related
  • Share

Most Recently Shared on August 9, 2010 at 9:50 pm By:

msnhealthnews msn Health News

Relieving Eye Pressure May Slow Glaucoma: http://bit.ly/beCc85

2 years ago...

Relieving Eye Pressure May Slow Glaucoma News - RealAge

realage.com — “Treatment most likely to help young patients with advanced damage, researchers sayView full resource at realage.com

  • View Related
  • Share

Most Recently Shared on August 10, 2010 at 5:41 pm By:

RealAge RealAge Health Site

Relieving eye pressure may slow glaucoma, especially in younger patients: http://bit.ly/cSNYqs

2 years ago...

Medical News: Pressure Reduction in Glaucoma Slows Progression - in Ophthalmology, Glaucoma from MedPage Today

medpagetoday.com — “A modest reduction in intraocular pressure resulted in a significant slowing of visual field loss in patients with progressive glaucoma, a Canadian study found.View full resource at medpagetoday.com

  • View Related
  • Share

Most Recently Shared on August 10, 2010 at 2:07 pm By:

medical_tweets medical_tweets Health News

Pressure Reduction in Glaucoma Slows Progression (CME/CE) (MedPage Today) -- A modest reduction in intraocular pressure.. http://dld.bz/rqEg

2 years ago...

Relieving Eye Pressure May Slow Glaucoma - Drugs.com MedNews

drugs.com — “Patients with glaucoma who have more rapid visual field change than other patients may benefit from a reduction of pressure within the eyeball, new research sugView full resource at drugs.com

  • View Related
  • Share

Most Recently Shared on August 9, 2010 at 10:25 pm By:

drugscom Drugs.com Health Site

Relieving Eye Pressure May Slow Glaucoma - http://bit.ly/cMDsTU

2 years ago...

Allergan, Inc. Receives FDA Approval for Lumigan 0.01% as First-Line Therapy Indicated for the Reduction of Elevated Intraocular Pressure in Glaucoma Patients

drugs.com — “Lumigan (bimatoprost) is used for the reduction of elevated intraocular pressure (IOP) in patients with open-angle glaucoma or ocular hypertension. Includes Lumigan side effects, interactions and indications.View full resource at drugs.com

  • View Related
  • Share

Most Recently Shared on September 5, 2010 at 11:24 pm By:

drugscom Drugs.com Health Site

FDA Approves Lumigan 0.01% for the Reduction of Elevated Intraocular Pressure in Glaucoma Patients - http://bit.ly/9f4yUQ

2 years ago...

Pressure Reduction in Glaucoma Slows Progression (CME/CE) - QualityPoint Technologies

qualitypointtech.net — “(MedPage Today) -- A modest reduction in intraocular pressure resulted in a significant slowing of visual field loss in patients with progressive glaucoma, a Canadian study found.View full resource at qualitypointtech.net

  • View Related
  • Share

Most Recently Shared on August 10, 2010 at 1:51 pm By:

MedicalFeed MedicalFeed Health News Feed

Pressure Reduction in Glaucoma Slows Progression (CME/CE): (MedPage Today) -- A modest reduction in intraocular pr... http://bit.ly/bHlbtK

2 years ago...

Allergan - Allergan, Inc. Receives FDA Approval for LUMIGAN(R) 0.01% as First-Line Therapy Indicated for the Reduction of Elevated Intraocular Pressure in Glaucoma Patients

agn.client.shareholder.com — “Allergan - Allergan, Inc. Receives FDA Approval for LUMIGAN(R) 0.01% as First-Line Therapy Indicated for the Reduction of Elevated Intraocular Pressure in Glaucoma PatientsView full resource at agn.client.shareholder.com

  • View Related
  • Share

Most Recently Shared on September 1, 2010 at 1:27 pm By:

eyeonfda eyeonfda Pharma and Health Lawyer

Allergan Gets FDA Approval 4 LUMIGAN(R) 1st-Line Tx 4 Reduction of Elevated Intraocular Pressure in Glaucoma Patients - http://ow.ly/2xRWT

2 years ago...

NDA Accepted for Saflutan for Glaucoma - ONA

oncologynurseadvisor.com — “Merck announced that the FDA has accepted its New Drug Application for Saflutan (tafluprost ophthalmic solution) for the reduction of elevated intraocular pressure (IOP) in patients with primary open-angle glaucoma or ocular hypertension.View full resource at oncologynurseadvisor.com

  • View Related
  • Share

Most Recently Shared on March 9, 2011 at 6:23 pm By:

NDA Accepted for Saflutan for Glaucoma - MPR

empr.com — “Merck announced that the FDA has accepted its New Drug Application for Saflutan (tafluprost ophthalmic solution) for the reduction of elevated intraocular pressure (IOP) in patients with primary open-angle glaucoma or ocular hypertension.View full resource at empr.com

  • View Related
  • Share

Most Recently Shared on March 9, 2011 at 6:53 pm By:

eMPR MPR Medical Publisher

MPR News: NDA Accepted for Saflutan for Glaucoma: Merck announced that the FDA has accepted its New Drug Applica... http://bit.ly/dFl7IR

1 year ago...

Reducing IOP Slows Progression of Vision Loss from Glaucoma

eyedocnews.com — “According to an article appearing yesterday on MedPage Today, a Canadian study has demonstrated that a modest reduction in intraocular pressure resulted in aView full resource at eyedocnews.com

  • View Related
  • Share

Most Recently Shared on August 11, 2010 at 10:35 pm By:

eyedocnews Dr. Ari Weitzner Doctor, Ophthalmologist, and Physician

Discuss: Does a Modest Reduction in Intraocular Pressure Slow Vision Loss in Glaucoma Patients?: By Dr. Ari Weitzn... http://bit.ly/8ZmJQw

2 years ago...

QLT Shows Positive 4 Week Efficacy in Phase II Study for Glaucoma Using Latanoprost Punctal Plug Delivery System - Drugs.com MedNews

drugs.com — “First reported demonstration of a clinically significant, prolonged (4 weeks) reduction in intraocular pressure (IOP) in glaucoma with an extraocular, minimallyView full resource at drugs.com

  • View Related
  • Share

Most Recently Shared on August 30, 2011 at 3:14 pm By:

Drugs_Devices Drugs and Devices OW OW Health

QLT Shows Positive 4 Week Efficacy in Phase II Study for Glaucoma Using Latanoprost Punctal Plug Delivery ... http://t.co/dThmFG7 #drug

9 months ago...

Neptazane tablets available for lowering intraocular pressure - ONA

oncologynurseadvisor.com — “Fera has made available Neptazane (methazolamide tablets) for the treatment of ocular conditions where lowering intraocular pressure is likely to be of therapeutic benefit, such as chronic open-angle glaucoma, secondary glaucoma, and preoperatively in acute angle-closure glaucoma where lowering the intraocular pressure is desired before surgery.View full resource at oncologynurseadvisor.com

  • View Related
  • Share

Most Recently Shared on July 6, 2010 at 3:53 pm By:

Neptazane tablets available for lowering intraocular pressure - MPR

empr.com — “Fera has made available Neptazane (methazolamide tablets) for the treatment of ocular conditions where lowering intraocular pressure is likely to be of therapeutic benefit, such as chronic open-angle glaucoma, secondary glaucoma, and preoperatively in acute angle-closure glaucoma where lowering the intraocular pressure is desired before surgery.View full resource at empr.com

  • View Related
  • Share

Most Recently Shared on July 6, 2010 at 3:32 pm By:

eMPR MPR Medical Publisher

MPR News: Neptazane tablets available for lowering intraocular pressure: Fera has made available Neptazane (methaz... http://bit.ly/9j937j

2 years ago...

Anticardiolipin Antibodies and Age Associated With Faster Visual Field Change in Glaucoma - QualityPoint Technologies

qualitypointtech.net — “A new study identified factors associated with the fastest rate of visual field change in patients with glaucoma and found that a modest reduction in intraocular pressure slowed rate of change. Medscape Medical NewsView full resource at qualitypointtech.net

  • View Related
  • Share

Most Recently Shared on August 17, 2010 at 11:18 pm By:

MedicalFeed MedicalFeed Health News Feed

Anticardiolipin Antibodies and Age Associated With Faster Visual Field Change in Glaucoma: A new study identified ... http://bit.ly/9mak9g

2 years ago...

Drug Delivery System Demonstrates Efficacy in Reducing Intraocular Pressure

eyedocnews.com — “After 4 weeks of L-PPDS treatment, the mean IOP reduction from baseline was -5.7 mmHgView full resource at eyedocnews.com

  • View Related
  • Share

Most Recently Shared on August 30, 2011 at 3:24 pm By:

eyedocnews Dr. Ari Weitzner Doctor, Ophthalmologist, and Physician

Discuss: QLT Shows Positive 4 Week Efficacy in Phase II Study for Glaucoma Using Latanoprost Punctal Plug Delive... http://t.co/bZBbuEa

9 months ago...

The Top 3 resources shared on this topic. More resources.

Key stats and trends about this topic

Featuring the top 3 experts for this topic

Advertisement

Share via Email

Share this WisdomCard with others by embedding on your site or blog.

300x260

425x300

560x390